Ex-Bristol-Myers Squibb Exec Admits To Insider Trading
A former Bristol-Myers Squibb Co. executive pled guilty Monday to securities fraud charges in New Jersey federal court, admitting he committed insider trading by purchasing stock options in a biotechnology company...To view the full article, register now.
Already a subscriber? Click here to view full article